Orally administered prajmalium bitartrate in acute and chronic ventricular arrhythmias.
D000328:Adult; D000368:Aged; D000404:Ajmaline / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use*; D005117:Cardiac Complexes, Premature / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006352:Heart Ventricles; D006801:Humans; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy; D011342:Procainamide / Q000009:adverse effects / Q000627:therapeutic use; D000644:Quaternary Ammonium Compounds / Q000009:adverse effects / Q000627:therapeutic use; D013997:Time Factors
D000889:Anti-Arrhythmia Agents; D000644:Quaternary Ammonium Compounds; D000404:Ajmaline; D011342:Procainamide